Revision history of "Insufficient GFR1 helps bring about hepatocellular carcinoma development yet improves oxaliplatinmediated antitumor effectiveness"

From EECH Central
Jump to: navigation, search

Diff selection: Mark the radio boxes of the revisions to compare and hit enter or the button at the bottom.
Legend: (cur) = difference with latest revision, (prev) = difference with preceding revision, m = minor edit.

  • (cur | prev) 08:30, 11 May 2024Freonoboe04 (Talk | contribs). . (3,550 bytes) (+3,550). . (Created page with "8% had been non-clinical workers, along with 69.8% had been patients/caregivers. Fewer than half from the patients/caregivers had the opportunity to get immunized (42%), as we...")